If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
215.00    -5.60 (-2.54%)
Bid:
214.60
Ask:
215.00
Spread: 0.40 (0.186%)
Market Cap: £1.40b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Result of AGM

18 Oct 2019 15:32

RNS Number : 4383Q
Ashmore Group PLC
18 October 2019
 

 

Ashmore Group plc (the "Company")

18 October 2019

Results of Annual General Meeting ("AGM")

 

 

The Board of Ashmore Group plc (the "Board"), is pleased to announce that at the AGM of the Company held earlier today, all resolutions were duly passed on a poll. All of the resolutions are accordingly, declared as carried. Resolutions 5, 6, 7 and 8, relating to the re-election of Independent Non-Executive Directors, are carried by a majority of votes cast by both Independent Shareholders as well as by a majority of votes cast by all shareholders.

The Company has noted that whilst there was an increase in shareholder support for the Remuneration Report by comparison to the 2018 AGM, the vote of independent shareholders against the Chair of the Remuneration Committee was 21.87%. During the year, the Company undertook a programme of engagement with its shareholders and the proxy advisers in an effort to understand their views on remuneration and this led to the Company making enhancements to its disclosure. The feedback received by the Company on this disclosure has been positive and the Company will continue the dialogue with shareholders.

 

The results of the poll on each resolution were as follows:

 

 

 

 

 

Resolution number:

FOR

AGAINST

ABSTAIN*

TOTAL VOTE

 

% age of total votes in favour

No. of Votes

 

No. of Votes

 

No. of Votes

 

1

 

To receive and adopt the Report and Accounts for the year ended 30 June 2018

603,245,647

0

303,837

603,245,647

100.00

2

 To declare a final dividend for the year ended 30 June 2018 of 12.1 pence per Ordinary Share

603,549,404

80

0

603,549,484

100.00

3

To re-elect Mark Coombs as a Director

600,130,661

3,418,243

500

603,548,904

99.43

4

To re-elect Tom Shippey as a Director

590,849,545

12,699,359

500

603,548,904

97.90

5

To re-elect Clive Adamson as a Director (all shareholders)

549,060,940

54,487,964

500

603,548,904

90.97

5

To re-elect Clive Adamson as a Director (independent shareholders)

282,621,680

 

54,487,964

 

500

 

337,109,644

 

83.84

 

6

 To re-elect David Bennett as a Director (all shareholders)

546,199,502

 

57,349,401

 

500

 

603,548,903

 

90.50

 

6

 To re-elect David Bennett as a Director (independent shareholders)

279,760,242

 

57,349,401

 

500

 

337,109,643

 

82.99

 

7

To elect Jennifer Bingham as a Director (all shareholders)

544,843,654

 

58,705,250

 

500

 

603,548,904

 

90.27

 

7

To elect Jennifer Bingham as a Director (independent shareholders)

278,404,394

 

58,705,250

 

500

 

337,109,644

 

82.59

 

8

To re-elect Dame Anne Pringle as a Director (all shareholders)

526,407,445

 

72,757,283

 

4,384,675

 

599,164,728

 

87.86

 

8

To re-elect Dame Anne Pringle as a Director (independent shareholders)

259,968,185

 

72,757,283

 

4,384,675

 

332,725,468

 

78.13

 

9

To approve the Remuneration Report for the year ended 30 June 2018

481,052,713

86,023,844

36,472,846

567,076,557

84.83

10

To re-appoint KPMG LLP as auditors

591,036,420

12,511,011

2,052

603,547,431

97.93

11

To authorise the Audit and Risk Committee to agree the remuneration of the auditors

598,922,329

4,626,655

500

603,548,984

99.23

12

To authorise political donations and political expenditure

600,928,214

2,617,344

3,846

603,545,558

99.57

13

To authorise the Directors to allot shares

593,250,328

10,297,476

1,600

603,547,804

98.29

14

To authorise the dis-application of pre-emption rights up to 35,637,040 shares**

603,538,335

7,995

3,074

603,546,330

100.00

15

To authorise the dis-application of pre-emption rights up to a further 35,637,040 shares**

595,201,029

8,345,300

3,074

603,546,329

98.62

16

To authorise market purchases of shares**

601,280,869

2,033,546

235,068

603,314,415

99.66

17

To approve the renewal of the waiver of the obligation under Rule 9 of the Takeover Code ***

319,826,995

17,281,548

1,601

337,108,543

94.87

18

To reduce the notice period for general meetings other than an Annual General Meeting**

591,172,632

12,376,772

0

603,549,404

97.95

 

 

* A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.

 

** Indicates Special Resolutions requiring a 75% majority

*** Mark Coombs has not voted on Resolution 17 as an interested party

 

Ashmore Group PLC's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12

 

In accordance with LR 9.6.2R, copies of resolutions concerning special business passed at the Annual General Meeting today, have been submitted to the Financial Conduct Authority's national storage mechanism. This document will shortly be available to view at www.morningstar.co.uk/uk/NSM

 

 

 

For further details, please contact:

 

John Taylor

Group Company Secretary

Ashmore Group plc

61 Aldwych

London WC2B 4AE

 

(T) +44 (0)20 3077 6000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGMPBITMBJBBML
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.